Free Trial

Generation Bio (GBIO) Insider Trading & Ownership

Generation Bio logo
$1.35 -0.04 (-2.88%)
(As of 11/20/2024 ET)

Generation Bio (NASDAQ:GBIO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
21.10%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$19,159.34
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$22,370.96
Get GBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Generation Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GBIO Insider Buying and Selling by Quarter

Generation Bio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/1/2024Antoinette PaoneCOOSell6,719$2.74$18,410.06  
1/2/2024Antoinette PaoneCOOSell2,445$1.62$3,960.90  
12/8/2023Dannielle AppelhansDirectorBuy637$1.82$1,159.34  
12/4/2023Dannielle AppelhansDirectorBuy12,000$1.50$18,000.00  
(Data available from 1/1/2013 forward)

GBIO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Generation Bio includes Antoinette Paone, Charles A Rowland Jr, Dannielle Appelhans, Donald William Nicholson, and Phillip Samayoa. Learn more on insiders at GBIO.

21.10% of Generation Bio stock is owned by insiders. Learn more on GBIO's insider holdings.

The following insider purchased GBIO shares in the last 24 months: Dannielle Appelhans ($19,159.34).

Insiders have purchased a total of 12,637 GBIO shares in the last 24 months for a total of $19,159.34 bought.

The following insiders have sold GBIO shares in the last 24 months: Antoinette Paone ($66,150.58), and Phillip Samayoa ($26,013.79).

Insiders have sold a total of 22,870 Generation Bio shares in the last 24 months for a total of $92,164.37 sold.

Generation Bio Key Executives

  • Dr. Cameron Geoffrey McDonough M.D. (Age 54)
    President, CEO & Director
    Compensation: $939.09k
  • Dr. Matthew Norkunas M.B.A. (Age 45)
    M.D., Chief Financial Officer
    Compensation: $611.11k
  • Dr. Matthew Stanton Ph.D. (Age 50)
    Chief Scientific Officer
    Compensation: $654.83k
  • Dr. Mark D. Angelino Ph.D. (Age 51)
    Co-Founder
  • Dr. Robert Kotin Ph.D. (Age 68)
    Co-Founder
  • Ms. Antoinette Paone M.B.A. (Age 45)
    M.S., Chief Operating Officer
    1 recent trades
  • Ms. Yalonda Howze J.D. (Age 51)
    Chief Legal Officer & Secretary
  • Ms. Jasmin Tower
    Chief Human Resources Officer
  • Dr. Phillip Samayoa Ph.D. (Age 36)
    Chief Strategy Officer


This page (NASDAQ:GBIO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners